Showing results 21 to 40 of 87
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2004 | Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre | Jittiwutikarn, J.; Ali, R.; White, J.; Bochner, F.; Somogyi, A.; Foster, D. |
| 2011 | Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis | Srisurapanont, M.; Arunpongpaisal, S.; Wada, K.; Marsden, J.; Ali, R.; Kongsakon, R. |
| 2016 | Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users | McKetin, R.; Gardner, J.; Baker, A.; Dawe, S.; Ali, R.; Voce, A.; Leach, L.; Lubman, D.; Australasian Professional Society on Alcohol and other Drugs Conference 2016 (30 Oct 2016 - 2 Nov 2016 : Sydney, Australia) |
| 2020 | Data resource profile: the Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, Australia | Larney, S.; Jones, N.; Fiellin, D.A.; Nielsen, S.; Hickman, M.; Dobbins, T.; Murphy, T.; Ali, R.; Degenhardt, L. |
| 2016 | Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia | Larance, B.; Mattick, R.; Ali, R.; Lintzeris, N.; Jenkinson, R.; White, N.; Kihas, I.; Cassidy, R.; Degenhardt, L.; Wilkinson, C.; Livingston, M. |
| 2013 | Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study | McKetin, R.; Lubman, D.; Baker, A.; Dawe, S.; Ali, R. |
| 2012 | Drug policy in Vietnam: a decade of change? | Vuong, T.; Ali, R.; Baldwin, S.; Mills, S. |
| 2005 | Effectiveness of drug dependence treatment in HIV prevention | Farrell, M.; Gowing, L.; Marsden, J.; Ling, W.; Ali, R. |
| 2015 | Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol | Degenhardt, L.; Larance, B.; Bruno, R.; Lintzeris, N.; Ali, R.; Farrell, M. |
| 2022 | Examining the cost and impact of dosing fees among clients in opioid agonist treatment: results from a cross-sectional survey of Australian treatment clients | Zahra, E.; Chen, R.; Nielsen, S.; Tran, A.D.; Santo, T.; Degenhardt, L.; Farrell, M.; Byrne, J.; Ali, R.; Larance, B. |
| 2008 | Exposure to opioid maintenance treatment reduces long-term mortality | Gibson, A.; Degenhardt, L.; Mattick, R.; Ali, R.; White, J.; O'Brien, S. |
| 2005 | Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS) | Darke, S.; Ross, J.; Teesson, M.; Ali, R.; Cooke, R.; Ritter, A.; Lynskey, M. |
| 2008 | Flexible dosing of Tincture of Opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics | Somogyi, A.; Larsen, M.; Abadi, R.; Jittiwutikarn, J.; Ali, R.; White, J. |
| 2018 | Global statistics on alcohol, tobacco and illicit drug use: 2017 status report | Peacock, A.; Leung, J.; Larney, S.; Colledge, S.; Hickman, M.; Rehm, J.; Giovino, G.A.; West, R.; Hall, W.; Griffiths, P.; Ali, R.; Gowing, L.; Marsden, J.; Ferrari, A.J.; Grebely, J.; Farrell, M.; Degenhardt, L. |
| 1996 | Heroin overdose: the case for take-home naltrexone | Strang, J.; Darke, S.; Hall, W.; Farrell, M.; Ali, R. |
| 2004 | HIV in injecting drug users in Asian countries | Wodak, A.; Ali, R.; Farrell, M. |
| 2005 | HIV in injecting drug users in Asian countries - Reply | Wodak, A.; Ali, R.; Farrell, M. |
| 2001 | Hyperalgesic responses in methadone maintenance patients | Doverty, M.; White, J.; Somogyi, A.; Bochner, F.; Ali, R.; Ling, W. |
| 1996 | Improvements in retention rates and changes in client groups with methadone maintenance streaming. | White, J.; Ryan, C.; Ali, R. |
| 2009 | Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation | Degenhardt, L.; Larance, B.; Bell, J.; Winstock, A.; Lintzeris, N.; Ali, R.; Scheuer, N.; Mattick, R. |
